高级检索+

外源rIL-17a对金黄色葡萄球菌感染的影响

The effect of exogenous rIL-17a on Staphylococcus aureus infection

  • 摘要: 为了探索外源重组白细胞介素17a(rIL-17a)对金黄色葡萄球菌感染的影响,试验在小鼠背部皮内注射金黄色葡萄球菌923与不同剂量(0.2μg、0.4μg、0.6μg、0.8μg、1.0μg)rIL-17a或牛血清白蛋白(BSA)的混合液,测定接种后不同时间点rIL-17a组和BSA组小鼠感染部位的伤口面积,接种6 d后血液、感染部位皮肤、肝脏、肾脏和脾脏内细菌数以及小鼠体重。结果表明:0.2μg rIL-17a与金黄色葡萄球菌混合皮内注射小鼠可极显著或显著减小感染第1,3天伤口面积(P<0.01或P<0.05),1.0μg rIL-17a可使感染第3天小鼠伤口面积显著增大(P<0.05)。感染6 d后,0.2μg和0.8μg rIL-17a组小鼠单位体积血液中的细菌数极显著低于相应剂量的BSA组(P<0.01),rIL-17a组和BSA组间皮肤内细菌数差异不显著(P>0.05),0.2μg rIL-17a组单位重量肝脏内细菌数极显著低于0.2μg BSA组(P<0.01),1.0μg rIL-17a组单位重量肝脏内细菌数则极显著高于1.0μg BSA组(P<0.01),1.0μg rIL-17a组单位重量肾脏内细菌数显著低于1.0μg BSA组(P<0.05),单位重量脾脏内细菌数在rIL-17a组和BSA组间的差异未达到统计学显著水平(P>0.05)。0.2μg和0.6μg rIL-17a组第5,6天可显著或极显著降低金黄色葡萄球菌对小鼠体重的抑制作用(P<0.05或P<0.01)。说明适当剂量的rIL-17a有助于皮肤感染处伤口愈合、血液和肝脏内金黄色葡萄球菌的清除、降低金黄色葡萄球菌对体重的影响;高剂量的rIL-17a不仅不利于清除细菌和促进伤口愈合,反而有利于细菌的生存和伤口恶化。

     

    Abstract: In order to explore the effect of exogenous recombinant interleukin 17 a(rIL-17 a) on Staphylocococcus aureus,a mixture of Staphylococcus aureus 923 and rIL-17 a(0.2 μg、0.4 μg、0.6 μg、0.8 μg、1.0 μg) or BSA were inoculated intracutaneously on the back of mice in this experiment. Wound sizes of the inoculation sites in rIL-17 a group and BSA group were measured at different time post inoculation,as well as bacteria counts in blood,inoculation sites,liver,kidney and spleen on 6 days post infection, and the body weights of mice were also calculated. The results showed that the mixture group of Staphylococcus aureus and 0.2 μg rIL-17 a inoculated intracutaneously could very significantly(P<0.01) and significantly(P<0.05) reduce wound sizes on day 1 and 3 post inoculation respectively. The mixture group with 1.0 μg rIL-17 a could increase significantly wound sizes of mice on day 3(P<0.05). On day 6 post inoculation,0.2 μg and 0.8 μg rIL-17 a groups had very significantly lower counts of Staphylococcus aureus than BSA group in mice blood per mL(P<0.01), rIL-17 a group and BSA group had no significant difference of bacteria counts in the inoculation sites(P>0.05),0.2 μg rIL-17 a group had very significantly lower bacteria counts than 0.2 μg BSA group in unit weight of liver(P<0.01). 1.0 μg rIL-17 a group had very significantly higher bacteria counts than 1.0 μg BSA group in unit weight of liver(P<0.01). 1.0 μg rIL-17 a group had significantly lower bacteria counts than 1.0 μg BSA group in unit weight of kidney(P<0.05). The rIL-17 a group and BSA group had no significant difference of bacteria counts in unit weight of spleen(P>0.05). In fifth and sixth day, 0.2 μg and 0.6 μg rIL-17 a groups could significantly(P<0.05) and very significantly(P<0.01), reduce the inhibitory effect of Staphylococcus aureus on mouce body weights respectively. The results suggested that an appropriate dose of rIL-17 a could be helpful to wound healing at the inoculation site,to the elimination of Staphylococcus aureus from mouse blood and liver,and to the reduction of the inhibition effect of Staphylococcus aureus on mouse body weight. High dose of rIL-17 a could be harmful to bacteria elimination and wound healing,and could be helpful to bacteria survival and wound worsening inversely.

     

/

返回文章
返回